Skip to main content

Testosterone Gel Study Looks at Artery Hardening

By October 6, 2015April 5th, 2022Pharmaceutical litigation, Testosterone
carey danis lowe logo w

The news has been overrun of late by research connecting testosterone replacement therapy with poor cardiovascular health. Though testosterone gel’s effects on heart health continue to be a major concern, a group of researchers decided to focus their attention on atherosclerosis, or artery hardening, in men using testosterone gel.

The study, published in the Journal of the American Medical Association (JAMA) in August 2015, followed 308 men over the course of 3 years. The men were over 60 years of age, and had low testosterone levels.

The researchers prescribed some of the men a testosterone gel, while other study participants used a placebo gel.

By year 3, the researchers concluded that the use of testosterone gel didn’t impact artery hardening in older men.

However, in reporting these findings in an interview with JAMA, one of the researchers urged that there needs to be larger clinical trials looking at heart health and testosterone use to shed more light on whether testosterone replacement therapy is safe for older men.


If you used testosterone gel, such as AndroGel or Axiron, and suffered a heart attack or stroke, you may be eligible to receive compensation. The testosterone lawyers at Carey Danis & Lowe are available to discuss your case during a free consultation. We’ll guide you through your legal options, and help you determine if filing a testosterone gel lawsuit is right for you.

You can reach one of our testosterone lawyers by phone at 800.721.2519, or by completing a confidential personal injury claim form.

You may be interested in reading: